-
Greece Health minister Vassilis Kikilias said on Tuesday that the country will receive in instalments three million doses of the potential COVID-19 vaccine developed by the University of Oxford in collaboration with AstraZeneca if it passes the Phase IV trial, which is expected to be completed in November, as reported Kathimerini.
-
"At the end of December, January, February, March, May and June, if all goes well, Greece will receive in seven partial deliveries its allocation from the agreed vaccine," Kikilias said.
-
"We will start with 700,000 doses in December which will be a single or double dose, and around 3 million doses in total," he added.
To read more NewsPoints articles, click here.
